Keywords: مونتلوکاست; Asthma; Drug therapy; Montelukast; Pediatrics; Randomized controlled trial; GINA; Global Initiative for Asthma; EPR-3; Expert Panel Reports 3; JGCA; Japanese guideline for childhood asthma; ICS; inhaled corticosteroid; SpO2; oxygen saturation of periphera
مقالات ISI مونتلوکاست (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مونتلوکاست; Endometrial hyperplasia; Estradiol valerate; Female rats; Montelukast;
Keywords: مونتلوکاست; Abdominal aortic aneurysm; Asthma; Cysteinyl-leukotrienes; Receptor antagonist; Montelukast;
Keywords: مونتلوکاست; atopic dermatitis; eicosanoids; leukotrienes; montelukast; pharmacology; prostaglandins; timapiprant; zileuton; COX; cyclooxygenase; CPLA2; cytosolic phospholipase A2; CRTH2; chemoattractant receptor homologous molecule expressed on T helper type 2; LT; l
Keywords: مونتلوکاست; Montelukast; Neuroprotection; Leukotrienes; TNFα;
Keywords: مونتلوکاست; Montelukast; Mometasone furoate; Allergic rhinitis; Sniffin' Sticks test;
Keywords: مونتلوکاست; asthma; combination therapy; montelukast; low-molecular-weight heparin; pulmonary delivery; microparticles;
Keywords: مونتلوکاست; Remote hind limb preconditioning; Cardioprotection; Leukotrienes; Montelukast; Zileuton
Keywords: مونتلوکاست; Childhood asthma; Inhaled corticosteroids; Montelukast; Sputum eosinophilia; Bronchial hyperreactivity; Exhaled nitric oxide
Keywords: مونتلوکاست; Inflammation; Leukotrienes; Montelukast; Pregnant rats; Tocolytics; Uterine contractions;
Keywords: مونتلوکاست; Bronchiolitis obliterans syndrome; Fluticasone; Azithromycin; Montelukast; Hematopoietic cell transplantation; Lung chronic graft-versus-host disease; Leukotrienes
Keywords: مونتلوکاست; Antinociception; Montelukast; Opioid receptors; Potentiation; Formalin test; Wrighting;
Keywords: مونتلوکاست; Electrospraying; Poly (lactic-co-glycolic acid); Montelukast; Drug-eluting stents; In-stent restenosis;
Keywords: مونتلوکاست; Asthma; Bronchoconstriction; Eicosanoids; Leukotriene; Montelukast;
Keywords: مونتلوکاست; Endometriosis; Rat; Montelukast; MMP-2; VEGF
Keywords: مونتلوکاست; Acute bronchiolitis; Eotaxin; IL-4; IL-8; IFN-gamma; Montelukast;
Keywords: مونتلوکاست; Childhood asthma; ICS use; Exacerbations; Exercise-induced bronchoconstriction; Montelukast; ICS; inhaled glucocorticosteroids; EIB; exercise-induced bronchoconstriction; FeNO; fractional exhaled nitric oxide; ACT; asthma control test; ETC; exercise tread
Keywords: مونتلوکاست; asthma; drug tolerability; FDA; leukotriene inhibitors; montelukast; risk communication;
Keywords: مونتلوکاست; Children; Adolescents; Step-down therapy; Montelukast; Inhaled corticosteroids; Asthma;
Keywords: مونتلوکاست; budesonide; doxofylline; formoterol; montelukast; tiotropium;
Keywords: مونتلوکاست; Asthma; inhaled corticosteroids; montelukast
Keywords: مونتلوکاست; Montelukast; Airway epithelial cells; Cytokines; Chemokines; Inflammation;
Keywords: مونتلوکاست; Airway smooth muscle; Animal model; Chronic lung diseases; Montelukast; Salbutamol; COPD; chronic obstructive pulmonary diseases; BSMC; bronchial smooth muscle cells;
Keywords: مونتلوکاست; Montelukast; smoking; fluticasone propionate; leukotriene receptor antagonist; asthma control; corticosteroids; AE; Adverse experience; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; PEF; Peak expiratory flow; SABA; Short-acting
The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide
Keywords: مونتلوکاست; Osteoblast; LPS; MMP-13; Montelukast;
Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes
Keywords: مونتلوکاست; Fibroblast-like synoviocytes; Montelukast; p65; IL-1β; Rheumatoid arthritis;
Antagonism of cysteinyl leukotriene receptor 1 (cysLTR1) by montelukast suppresses cell senescence of chondrocytes
Keywords: مونتلوکاست; Osteoarthritis; cysLTR1; Senescence; P53; Montelukast;
Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies
Keywords: مونتلوکاست; AA; arachidonic acid; CV; Cardiovascular; CysLTs; cysteinyl leukotrienes; CysLTR; cysteinyl leukotrienes receptor; LT; leukotrienes; LTRA; leukotrienes receptor antagonist; Leukotriene receptor antagonist; Montelukast; Cardiovascular event; Cysteinyl leuk
A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis
Keywords: مونتلوکاست; allergic rhinitis; asthma; clinical trial; fixed-dose combination; levocetirizine; montelukast;
Cysteinyl leukotriene receptor 1 regulates glucose-stimulated insulin secretion (GSIS)
Keywords: مونتلوکاست; Type 2 diabetes mellitus; Glucose-stimulated insulin secretion; Cysteinyl leukotrienes; Montelukast; Arf6;
Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages
Keywords: مونتلوکاست; Chemokine; M2 macrophage; Mitogen-activated protein kinase; Montelukast; Nuclear factor-κB;
Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects
Keywords: مونتلوکاست; Parkinson's disease; Rotenone; Montelukast; Neuroinflammation; p38MAPK; Microglia;
Comparaison des effets des corticostéroïdes par voie nasale et du montélukast sur les fonctions olfactives chez les patients atteints de rhinite allergique
Keywords: مونتلوکاست; Montélukast; Furoate de mométasone; Rhinite allergique; Test Sniffin' Sticks;
Full length articleProlonged, acute suppression of cysteinyl leukotriene to reduce capsular contracture around silicone implants
Keywords: مونتلوکاست; Cysteinyl leukotrienes; Fibrosis; Fibroblast; Montelukast; Myofibroblasts; Silicone implants; TGF-β;
Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis
Keywords: مونتلوکاست; Vascular cell adhesion molecule-1 (VCAM-1); Oxidized low-density lipoprotein (ox-LDL); Endothelial inflammation; Montelukast; Kruppel-like factor 2;
The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling
Keywords: مونتلوکاست; Cysteinyl leukotrienes; Montelukast; Tenon fibroblasts; Transforming growth factor-β1; Wound healing;
CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17
Keywords: مونتلوکاست; Purinergic receptors; Oligodendrocytes; Remyelination; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ATX; autotaxin; CNS; central nervous system; DRG; dorsal root ganglion; EAE; experimental autoimmune encephalomyelitis; GDNF; glial cell de
Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?
Keywords: مونتلوکاست; Allergic rhinitis; Oral antihistamine; Intranasal antihistamine; Intranasal corticosteroid; Leukotriene receptor antagonist; Minimal clinically important difference (MCID); Seasonal allergic rhinitis (SAR); Total nasal symptom score (TNSS); AHRQ; Agency f
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
Keywords: مونتلوکاست; Asthma; roflumilast; montelukast; phosphodiesterase 4 inhibitors; ACQ; Asthma Control Questionnaire; AE; Adverse event; ANCOVA; Analysis of covariance; ATS; American Thoracic Society; BMI; Body mass index; COPD; Chronic obstructive pulmonary disease; C-SS
Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice
Keywords: مونتلوکاست; Montelukast; Cysteinyl leukotriene receptor 1; Streptozotocin; Memory; Neurotoxicity;
Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies
Keywords: مونتلوکاست; Asthma; Beclomethasone; FEV1; Montelukast; Roflumilast
Montelukast prevents ischaemia/reperfusion-induced ovarian damage in rats
Keywords: مونتلوکاست; Montelukast; CysLT1 receptor; CO2 pneumoperitoneum; Laparoscopy; Reactive oxygen species; Ischaemia/reperfusion injury;
Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils
Keywords: مونتلوکاست; Airway remodeling; Asthma; Cysteinyl leukotrienes; Epithelial to mesenchymal transition; Eosinophils; Montelukast;
Montelukast rescues primary neurons against Aβ1–42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling
Keywords: مونتلوکاست; Montelukast; Cysteinyl leukotriene receptor 1; Amyloid-β; NF-κB
Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats
Keywords: مونتلوکاست; Fructose-induced metabolic syndrome; Montelukast; Irbesartan
Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice
Keywords: مونتلوکاست; Montelukast; Cysteinyl leukotriene receptor 1; Amyloid-β; NF-κB; Memory;
Montelukast photodegradation: Elucidation of Ф-order kinetics, determination of quantum yields and application to actinometry
Keywords: مونتلوکاست; Montelukast; Photodegradation; Spectrokinetics; Photoisomerism; Actinometry; Quantum yield;
Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma
Keywords: مونتلوکاست; Leukotriene antagonist; Leukotriene synthesis inhibitor; Asthma; Hypersensitivity; Montelukast
Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis
Keywords: مونتلوکاست; Allergic rhinitis; KOB03; Polyherbal medicine; Ketotifen; Montelukast; Efficacy;
Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells
Keywords: مونتلوکاست; Montelukast sodium (PubChem CID 23663996); Salbutamol emisulphate (PubChem CID 39859); Indomethacin (PubChem CID 3715); NS398 (PubChem CID 4553); Microparticles; Montelukast; β2-Agonists; Airway smooth muscle cell; Bronchial inflammation; Cell signaling;